Cargando…
Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy
We present a successful treatment, with tigecycline monotherapy, of acute prostatitis caused by multidrug-resistant Escherichia coli harboring an NDM-1 carbapemenase along with a CMY-2 cephalosporinase and a TEM ESBL.
Autores principales: | Lo Priore, Elia, Livermore, David M, Buetti, Niccolo, Jent, Philipp, Pelzer, Niklas, Casanova, Carlo, Furrer, Hansjakob, Babouee Flury, Baharak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975247/ https://www.ncbi.nlm.nih.gov/pubmed/31988977 http://dx.doi.org/10.1093/ofid/ofz551 |
Ejemplares similares
-
Gradual in vitro Evolution of Cefepime Resistance in an ST131 Escherichia coli Strain Expressing a Plasmid-Encoded CMY-2 β-Lactamase
por: Donà, Valentina, et al.
Publicado: (2019) -
Resistance development in Escherichia coli to delafloxacin at pHs 6.0 and 7.3 compared to ciprofloxacin
por: Bösch, Anja, et al.
Publicado: (2023) -
Pharmacokinetic Analysis and In Vitro Synergy Evaluation of Cefiderocol, Sulbactam, and Tigecycline in an Extensively Drug-Resistant Acinetobacter baumannii Pneumonia Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2022) -
Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018) -
Epidemiology of subsequent bloodstream infections in the ICU
por: Buetti, Niccolò, et al.
Publicado: (2018)